NFSG
TTOO

Newbridge Financial Services Group’s T2 Biosystems, Inc TTOO Stock Holding History

Newbridge Financial Services Group’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$42 – 1251
2024
Q1 		$30 Buy
+10
New +$47 ﹤0.01% 1163

Other funds holding TTOO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Newbridge Financial Services Group's TTOO Position: Q2 2024 in Review

Newbridge Financial Services Group sold out of T2 Biosystems, Inc (TTOO) in Q2 2024, closing a stake of 10 shares — an estimated $42 sold.

Newbridge Financial Services Group first reported a position in TTOO in Q1 2024 and held it in 1 quarter. The position peaked at $30 in Q1 2024. 21 funds tracked by Wall St. Rank hold TTOO as of Q2 2024.

  • Newbridge Financial Services Group reported no remaining T2 Biosystems, Inc position as of Q2 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 10 T2 Biosystems, Inc shares in Q2 2024, an estimated $42.
  • Newbridge Financial Services Group first reported a position in T2 Biosystems, Inc in Q1 2024 and held it in 1 quarter.
  • Newbridge Financial Services Group's T2 Biosystems, Inc position peaked at $30 in Q1 2024.
  • 21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2024.

Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.